Modeling kidney injury caused by drugs
Official title: Establishment, Evaluation and Treatment Strategy of Drug-induced Kidney Injury Model
Run by Zhejiang Provincial People's Hospital · NCT06939387 · Data updated 2026-11-12
This study is trying to find a way to predict kidney problems in patients who have had kidney injury from medications to help understand how different drugs affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Zhejiang Provincial People's Hospital Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | April 22, 2025 |
| Trial ID | NCT06939387 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have experienced acute kidney injury due to drug exposure.
✕Probably not a fit
Patients on dialysis, those without baseline creatinine data, or those with obstructive acute kidney injury may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a prediction model for renal dysfunction in patients who have experienced drug-induced acute kidney injury. It will analyze the prognosis associated with different drug treatments in these patients. By collecting and evaluating clinical data, the study seeks to identify patterns and outcomes related to kidney injury caused by medications.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of drug-induced kidney injury, leading to better patient outcomes.
How similar studies have gone: While there have been studies on acute kidney injury, this specific observational approach to modeling drug-induced injury is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Drug-induce acute kidney injury Exclusion Criteria: * 1.Dialysis patients; 2.No baseline creatinine; 3.Obstructive AKI; 4.Clinical data were incomplete.
Where it's running
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: xiaolan Ye, master
- Email: yexl1120@126.com
- Phone: +86-0571-85893117
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
-
Restarting RAS inhibitors after AKI: a quick test in hospitalized adults
This pilot study tests whether restarting renin-angiotensin system inhibitors early after acute kidney injury is feasible and safe in hospitalized adults already using these medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.